Drugmaker Novo Nordisk sales disappoint, sees lower 2019 U.S. prices
Shares in Novo Nordisk fell on Wednesday after sales of some of its key drugs in the second quarter fell short of expectations and it said prices in the key U.S. market would be lower next year.
from Reuters: Health News https://reut.rs/2ASoUx7
http://bit.ly/2zwRqiM